Internet-based Support for Adjustment to Prostate Cancer
Internet-based Support for Adjustment to Prostate Cancer (ISAC) - A Randomized Controlled Trial of ICBT for Distress Related to Prostate Cancer
Linkoeping University
180 participants
Jan 5, 2025
INTERVENTIONAL
Conditions
Summary
The study aims to study the efficacy of internet-based cognitive behavior therapy (ICBT) in reducing subjective distress and comorbid psychiatric symptoms in men diagnosed with prostate cancer. Participants who have been diagnosed with prostate cancer and are currently not undergoing or scheduled to undergo medical treatment will be recruited. Once recruited, they will be randomized to receive either a tailored, eight-week long ICBT intervention or an attention control group. Both group receive weekly support by a trained therapist.
Eligibility
Inclusion Criteria6
- Subjectively reported psychological symptoms and problems that have come about after a prostate cancer diagnosis.
- A sum score above 19 on the primary outcome measure (Kessler-10).
- An age of 18 or older.
- Ability to speak, read, and write Swedish.
- Access to a computer/laptop/tablet/smartphone and internet access.
- Sufficient computer profiency to be able to use the treatment platform.
Exclusion Criteria7
- Planned medical treatment or planned change in medication related to the prostate cancer during the treatment period.
- Recently finished (within the past six months) medical treatment for prostate cancer.
- Severe psychiatric or somatic conditions that impedes participation in the study.
- Ongoing substance use problems.
- Acute suicidality.
- Other ongoing psychological treatment.
- Psychopharmaceutic treatment that has been changed within the past month or with planned changes during the treatment phase.
Interventions
An eight week ICBT treatment. The treatment is modular and tailored to the problem profile of the participant. One module will be administered every week during the treatment phase.
Participants randomized to this condition will receive weekly support and contact with a therapist via the treatment platform. They will not have access to the treatment modules during the treatment phase.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06766526